Catheter Precision's EPS (Basic) for the
three
months ended in Dec. 2023 was $1.21.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-24.01.
During the past 3 years, the average EPS without NRIGrowth Rate was 87.80% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 79.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 8 years, Catheter Precision's highest 3-Year average EPS without NRI Growth Rate was 87.80% per year. The lowest was -131.90% per year. And the median was 59.20% per year.
Catheter Precision EPS (Diluted) Historical Data
The historical data trend for Catheter Precision's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Catheter Precision's EPS (Diluted)
For the Medical Devices subindustry, Catheter Precision's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catheter Precision's PE Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's PE Ratio distribution charts can be found below:
* The bar in red indicates where Catheter Precision's PE Ratio falls into.
Catheter Precision EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Catheter Precision's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-24.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Catheter Precision EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of Catheter Precision's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Catheter Precision (Catheter Precision) Business Description
Catheter Precision Inc Formerly Ra Medical Systems Inc is a commercial-stage medical device company whose business comprises of the design, manufacture and sale of new medical technologies in the field of cardiac electrophysiology, or EP. Its product, View into Ventricular Onset System or VIVO System which is a non invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. . It operates business as one segment which includes all activities related to the marketing, sales and development of medical technologies in the field of cardiac EP.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VTAK has been successfully added to your 